Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Type Project # RFA # PI/Project Leader Institution Title Statussort ascending
2021 R21 CA20-017 DEININGER, MICHAEL W VERSITI WISCONSIN, INC. A Bioluminescent Assay for Direct Measurement of Sirtuin Activity in Cancer Cells NCE
2020 R21 RFA-CA-19-019 REVZIN, ALEXANDER MAYO CLINIC ROCHESTER A microfluidic cell culture platform for personalizing pancreatic cancer therapies NCE
2020 R21 RFA-CA-19-019 ISSADORE, DAVID AARON UNIVERSITY OF PENNSYLVANIA High Throughput Digital Droplet ELISA for Ultrasensitive Multiplexed Diagnostics NCE
2020 R33 RFA-CA-19-020 LEVINSON, NICHOLAS MARK UNIVERSITY OF MINNESOTA Time-resolved FRET-based allostery sensors for any protein kinase drug target NCE
2021 R21 CA20-019 NAUTIYAL, SHIVANI PRIME GENOMICS, INC. Device for Preservation of Cell Free RNA in Saliva NCE
2021 R21 CA20-017 FARIS, GREGORY W NUMENTUS TECHNOLOGIES INC. Decoding Individual Exosomes in Cancer NCE
2000 R21 PAR-99-102 GRIFFITH, JEFFREY K UNIVERSITY OF NEW MEXICO PROGNOSTIC VALUE OF TELOMERE DNA IN PROSTATE BIOPSY Complete
2002 R33 PAR-98-067 SHERRY, A. DEAN UNIVERSITY OF TEXAS DALLAS MRI AGENTS SENSITIVE TO BIOLOGICAL INDICATORS OF NEOPLAS Complete
2005 R33 RFA-CA-05-003 FEDERSPIEL, MARK J MAYO CLINIC TECHNOLOGY TO OPTIMIZE SCFVS FOR TARGETING THERAPEUTICS Complete
2008 R33 RFA-CA-07-036 HAHN, WILLIAM C DANA-FARBER CANCER INST INTEGRATED GENOMIC APPROACHES TO IDENTIFY AND VALIDATE CANCER TARGETS Complete
2011 R33 RFA-CA-10-002 THOMAS, NANCY E UNIV OF NORTH CAROLINA CHAPEL HILL HIGH-THROUGHPUT DNA-METHYLATION PROFILING FROM FIXED MELANOCYTIC TISSUES Complete
2015 R33 RFA-CA-14-004 ZIPFEL, WARREN R CORNELL UNIVERSITY FAST INTERFERENCE-BASED SUPER-RESOLUTION MICROSCOPE FOR CANCER MECHANOBIOLOGY Complete
2018 R43 PAR-18-303 SCHOETTLE, LOUIS GEMNEO BIOSCIENCE, INC. Origami Nanoprobes for Large-Scale Single-Cell Analysis of Lymphocytes Complete
1999 R43 PAR-98-066 RICHTERICH, PETER CODONCODE CORPORATION SOFTWARE FOR SEQUENCING BASED MUTATION DETECTION Complete
2002 R21 PAR-01-104 YEUNG, EDWARD S. IOWA STATE UNIVERSITY SINGLE-MOLECULE IMMUNOASSAY AND DNA SCREENING Complete
2005 R21 RFA-CA-05-002 WANG, BINGHE GEORGIA STATE UNIVERSITY FLUORESCENT APTAMERS FOR GLYCOPROTEIN DETECTION Complete
2008 R21 RFA-CA-07-022 LIOTTA, LANCE ALLEN GEORGE MASON UNIVERSITY SURROGATE AND SENTINAL TECHNOLOGIES TO MONITOR STABILITY OF CANCER PHOSPHOPROTEIN Complete
2010 R44 RFA-CA-08-011 CHEN, WEN-TIEN VITATEX, INC. CANCER PROGENIYOR CELL MARKERS Complete
2015 R21 RFA-CA-14-003 ELLINGTON, ANDREW D UNIVERSITY OF TEXAS, AUSTIN HIGH THROUGHPUT SINGLE CELL TRANSCRIPTOME ANALYSIS Complete
2017 R44 PAR-13-327 PREMSRIRUT, PREM KHOVABUTR MIRIMUS, INC. Next generation CRISPR/Cas9-RNAi mouse models for accelerated drug discovery research Complete
1999 R21 PAR-98-067 VIDAL, MARC MASSACHUSETTS GENERAL HOSPITAL NEW TECHNOLOGIES FOR PROTEIN INTERACTION MAPPING Complete
2001 R33 PAR-99-100 MAJUMDAR, ARUNAVA UNIVERSITY OF CALIFORNIA BERKELEY OPTOMECHANICAL CHIPS FOR MOLECULAR PROFILING OF CANCER Complete
2003 R44 PAR-01-105 NEDELKOV, DOBRIN INTRINSIC BIOPROBES, INC. AFFINITY-BASED MASS SPECTROMETRY PROTEIN ASSAYS Complete
2007 R21 RFA-CA-07-002 YEE, CASSIAN FRED HUTCHINSON CAN RES CTR IDENTIFICATION OF T CELL-DEFINED ANTIGENS IN OVARIAN CANCER Complete
2010 R21 RFA-CA-09-004 WILLEY, JAMES C. UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS IMPLEMENTATION OF INNOVATIVE RNA SAMPLE QUALITY CONTROL METHODS Complete
2013 R33 RFA-CA-13-004 LIU, YU-TSUENG UNIVERSITY OF CALIFORNIA SAN DIEGO HIGH QUALITY CTC ISOLATION USING MICROBUBBLES FOR DOWNSTREAM MOLECULAR ANALYSIS Complete
2017 R21 RFA-CA-16-001 VAN DAM, ROBERT MICHAEL UNIVERSITY OF CALIFORNIA LOS ANGELES High-throughput radiochemistry platform for accelerated discovery and development of novel PET imaging agents for cancer Complete
2000 R43 PAR-99-101 KOGON, ALEX A BIOLINX, LLC THOMSEN-FRIEDERICH ANTIGEN ASSAY FOR CANCER SCREENING Complete
2002 R43 PAR-01-105 HANNA, MICHELLE M RIBOMED BIOTECHNOLOGIES, INC. RAPID ANALYSIS OF CPG METHYLATION CHANGES IN CANCER Complete
2006 R33 RFA-CA-06-002 CLAWSON, GARY A. PENNSYLVANIA STATE UNIV HERSHEY MED CTR AN RNA SENSOR FOR DETECTION OF CIRCULATING TUMOR CELLS Complete
2009 R21 RFA-CA-08-006 SHAPIRO, BENJAMIN UNIV OF MARYLAND, COLLEGE PARK SPATIAL, HIGH-ACCURACY, MULTIPLEXED MAPPING OF GENES IN HUMAN TISSUE SECTIONS Complete
2013 R21 RFA-CA-12-002 SOPER, STEVEN ALLAN UNIV OF NORTH CAROLINA CHAPEL HILL ACUTE MYELOID LEUKEMIA: MRD ANALYSIS USING MODULAR UFLUIDICS AND UFLOW CYTOMETRY Complete
2016 R33 RFA-CA-15-003 BREUNIG, JOSHUA JOHN CEDARS-SINAI MEDICAL CENTER A GENETIC TOOLBOX FOR THE IDENTIFICATION AND INTERROGATION OF TUMOR CELLS OF ORIGIN, PROPAGATION, AND RECURRENCE FROM PATIENT-DERIVED ONCOGENIC DRIVERS Complete
2019 R21 RFA-CA-18-004 SINGAMANENI, SRIKANTH WASHINGTON UNIVERSITY METAL-ORGANIC FRAMEWORK AS PROTECTIVE COATING FOR CANCER BIOSPECIMEN PRESERVATION Complete
2000 R21 PAR-99-102 OH, SEAJIN SRI INTERNATIONAL AFM BASED TECHNIQUE--ANALYZES EXPRESSION IN CANCER CELLS Complete
2002 R33 PAR-98-067 GIESE, ROGER WALLACE NORTHEASTERN UNIVERSITY CATION LABELING MASS SPECTROMETRY OF DNA ADDUCTS Complete
2005 R33 RFA-CA-05-003 D'ERRICO, FRANCESCO YALE UNIVERSITY CHEMOTHERAPY WITH INJECTABLE MICRODROPLETS Complete
2008 R33 RFA-CA-07-036 VIDAL, MARC DANA-FARBER CANCER INST APPLICATION OF TECHNOLOGIES FOR INTERACTOME NETWORK ANALYSES OF CANCER MUTATIONS Complete
2011 R33 RFA-CA-10-004 JU, JINGFANG STATE UNIVERSITY NEW YORK STONY BROOK IDENTIFICATION OF POST-TRANSCRIPTIONALLY REGULATED TARGETS BY TRIP-CHIP/SEQ Complete
2015 R33 RFA-CA-14-004 SCHWARTZ, DAVID C. UNIVERSITY OF WISCONSIN-MADISON SCALABLE CANCER GENOMICS VIA NANOCODING AND SEQUENCING Complete
2019 R43 PAR-18-303 KHODAVERDIAN, VARANDT Y. NUPROBE USA, INC. Allele selective enrichment for targeted profiling of rare cancer mutations via low-depth sequencing Complete
1999 R43 PAR-98-066 GOLDRICK, MARIANNA M AMBION, INC. DETECTION AND QUANTITATION OF FUSION MRNAS IN LEUKEMIA Complete
2002 R21 PAR-01-104 KNAPP, DANIEL R. MEDICAL UNIVERSITY OF SOUTH CAROLINA MICROFLUIDIC SYSTEM FOR CANCER PROTEOME ANALYSIS Complete
2005 R21 RFA-CA-05-002 GUDKOV, ANDREI V CLEVELAND CLINIC LERNER COL/MED-CWRU ISSA: NOVEL FUNCTIONAL APPROACH TO CANCER-RELATED GENES Complete
2008 R21 RFA-CA-07-033 LANDEGREN, ULF DAG UPPSALA UNIVERSITY DIAGNOSTIC ANALYSES OF ENDOGENOUS PROTEIN INTERACTIONS Complete
2011 R21 RFA-CA-10-001 HAGEDORN, CURT H. UNIVERSITY OF UTAH SENTINEL POL II RNAS FOR MEASURING RNA INTEGRITY IN BIOSPECIMENS Complete
2015 R21 RFA-CA-14-003 MACCOSS, MICHAEL UNIVERSITY OF WASHINGTON SYSTEMATIC AND COMPREHENSIVE SAMPLING OF PEPTIDES IN MIXTURES BY TANDEM MASS SPECTROMETRY Complete
2018 R21 RFA-CA-17-010 ABBOTT, KAREN L UNIV OF ARKANSAS FOR MED SCIS Novel platform linking cancer-specific glycosylation with cell signaling outcomes Complete
1999 R21 PAR-98-067 GARNER, HAROLD R UNIVERSITY OF TEXAS SW MED CTR/DALLAS SOFTWARE AND INSTRUMENTATION TO IDENTIFY CANCER GENES Complete
2001 R33 PAR-99-100 HERLYN, DOROTHEE M WISTAR INSTITUTE MOLECULAR CLONING OF HLA CLASS II TUMOR ANTIGENS Complete

Pages